![Laura Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Hansen
Contatto Relazioni con gli Investitori presso
DENALI THERAPEUTICS INC.
Profilo
Laura G.
Hansen is currently Vice President-Investor Relations at Denali Therapeutics, Inc. since 2020.
Former positions include Vice President-Corporate Affairs at BlackThorn Therapeutics, Inc. (2019–2020), Vice President-Investor Relations at Aimmune Therapeutics, Inc. (2016–2019), Senior Director-Corporate Communications at Threshold Pharmaceuticals, Inc. (2012–2016), Director-Corporate Communications at Kyntra Bio, Inc. (2002–2012), and Director-Corporate Communications at Corvas International, Inc. (2001–2002).
Education includes undergraduate and doctorate degrees from The University of Texas at Austin.
Posizioni attive di Laura Hansen
| Società | Posizione | Inizio |
|---|---|---|
| DENALI THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | 01/09/2020 |
Precedenti posizioni note di Laura Hansen
| Società | Posizione | Fine |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Corporate Officer/Principal | 01/09/2020 |
| AIMMUNE THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/03/2019 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Contatto Relazioni con gli Investitori | 01/02/2016 |
| KYNTRA BIO, INC. | Public Communications Contact | 01/07/2012 |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Public Communications Contact | 01/07/2002 |
Formazione di Laura Hansen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
43
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
